Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectives.
about
Ponatinib in refractory Philadelphia chromosome-positive leukemias.Survival regulation of leukemia stem cellsWnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl.Immature B-cell progenitors survive oncogenic stress and efficiently initiate Ph+ B-acute lymphoblastic leukemiaPhiladelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis.Treatment of human pre-B acute lymphoblastic leukemia with the Aurora kinase inhibitor PHA-739358 (Danusertib)Leukaemic infiltration of the mandible in a young girl.State-of-the-art in the management of chronic myelogenous leukemia in the era of the tyrosine kinase inhibitors: evolutionary trends in diagnosis, monitoring and treatment.ABL1 fusion genes in hematological malignancies: a review.Wnt signaling in leukemias and myeloma: T-cell factors are in control.Genomic characterization of acute leukemias.Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery.Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia.Resistance to farnesyltransferase inhibitors in Bcr/Abl-positive lymphoblastic leukemia by increased expression of a novel ABC transporter homolog ATP11a.A farnesyltransferase inhibitor increases survival of mice with very advanced stage acute lymphoblastic leukemia/lymphoma caused by P190 Bcr/Abl.High proportion of CD34+/CD38-cells is positively correlated with poor prognosis in newly diagnosed childhood acute lymphoblastic leukemia.Ponatinib-induced neutrophilic panniculitis.Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia
P2860
Q27851967-9A0AFA1D-4832-43A9-A173-66EFB5EC4CF3Q28271278-669608A2-B819-4164-B9A2-26D7D0ABD8EEQ33996893-449516E2-4AE3-419C-9282-4AEC24DE7468Q34193548-98107163-3EC8-4265-A587-BA1BA7F28BEBQ36115885-EBA0FC9E-EA09-47BE-A0B0-00AC8B674ABBQ36373227-EACFD41F-57B5-4AFF-801B-F89D9183AFC5Q36722493-E03366CB-7088-42E0-A7F2-14EFC58A8F24Q37657478-06A7EA59-8825-4807-AB23-4732A8A71BE5Q37857340-BA5D7933-A196-4F3E-AB69-B77EB6CFFDF3Q38155205-F0EDC8F8-2D95-4AC3-9311-9A866E30B38DQ38223490-827C4336-CAB5-4F9F-9D69-DC48E9CFA31DQ38383345-00883DE4-C96C-46BF-8A35-AD3CCD571EE5Q42017483-26A7D183-08A2-411E-AD94-CF75B6F17410Q42742534-F2E5BACF-8F6D-4AB2-ABC0-50F2546C200FQ44645852-BA149F00-E10D-42D2-8454-0D15CED9BEE2Q50962385-48A1F186-FBB0-4FA7-BA44-B9F58140141CQ54372623-B32ECF2D-951A-4044-B67A-EDBC519A6638Q59194346-19D95C51-48CE-462B-8277-5C5C347474E0
P2860
Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectives.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Philadelphia chromosome-positi ...... cepts and future perspectives.
@en
type
label
Philadelphia chromosome-positi ...... cepts and future perspectives.
@en
prefLabel
Philadelphia chromosome-positi ...... cepts and future perspectives.
@en
P2860
P50
P1476
Philadelphia chromosome-positi ...... cepts and future perspectives.
@en
P2093
Deborah A Thomas
P2860
P304
142-60; discussion 200-2
P356
10.1046/J.1468-0734.2002.00066.X
P577
2002-06-01T00:00:00Z